Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

225.00
+28.0014.21%
Post-market: 225.470.4683+0.21%19:59 EDT
Volume:28.95M
Turnover:6.23B
Market Cap:89.83B
PE:-28.10
High:225.00
Open:199.00
Low:197.17
Close:197.00
52wk High:225.00
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.44
T/O Rate:7.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:13.29
PE(LYR):-30.99

Loading ...

Option Focus | Moderna’s $979K October 2026 Call Credit Spread Caps Upside, Yet Bulk-Order Flow Still Leans Bullish Amid 99% IV Percentile

Option Witch
·
1 hour ago

Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Dow Jones
·
3 hours ago

US Equity Markets End Higher Amid Broad Rally, Strong Mega-Cap Gains

MT Newswires Live
·
3 hours ago

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
4 hours ago

Moderna Shares Rally After Addition to NASDAQ 100; BofA Raises Price Objective

Reuters
·
5 hours ago

Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why

TIPRANKS
·
5 hours ago

Moderna up over 11%, on Track for Highest Close Since January 2022

Dow Jones
·
6 hours ago

Sector Update: Healthcare

MT Newswires Live
·
6 hours ago

Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.

Dow Jones
·
7 hours ago

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

TIPRANKS
·
7 hours ago

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
7 hours ago

Top Midday Gainers

MT Newswires Live
·
7 hours ago

Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200

TradingKey
·
Yesterday

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09

Reuters
·
Yesterday

Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines

MT Newswires Live
·
Yesterday

NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump

MT Newswires Live
·
Yesterday

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Yesterday

BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 7.63% on Oct 9: A Full Analysis

TradingKey
·
Yesterday

Movement Alert|Moderna, Inc. Rises 3.96% in Regular Trading, Nasdaq-100 Inclusion Takes Effect and Cancer Vaccine Commercialization Optimism Grows

Market Focus
·
Yesterday